User profiles for Tommaso Rosà
 | Tommaso RosàResident in Anesthesiology and Intensive Care Medicine, Università Cattolica del Sacro … Verified email at icatt.it Cited by 620 |
Effect of helmet noninvasive ventilation vs high-flow nasal oxygen on days free of respiratory support in patients with COVID-19 and moderate to severe hypoxemic …
Importance High-flow nasal oxygen is recommended as initial treatment for acute hypoxemic
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
respiratory failure and is widely applied in patients with COVID-19. Objective To assess …
High failure rate of noninvasive oxygenation strategies in critically ill subjects with acute hypoxemic respiratory failure due to COVID-19
…, MC Ferrante, M Cesarano, GM Anzellotti, T Rosà… - Respiratory …, 2021 - rc.rcjournal.com
BACKGROUND: The efficacy of noninvasive oxygenation strategies (NIOS) in treating
COVID-19 disease is unknown. We conducted a prospective observational study to assess the …
COVID-19 disease is unknown. We conducted a prospective observational study to assess the …
Respective effects of helmet pressure support, continuous positive airway pressure, and nasal high-flow in hypoxemic respiratory failure: a randomized crossover …
LS Menga, L Delle Cese, T Rosà… - American Journal of …, 2023 - atsjournals.org
Rationale: The respective effects of positive end-expiratory pressure (PEEP) and pressure
support delivered through the helmet interface in patients with hypoxemia need to be better …
support delivered through the helmet interface in patients with hypoxemia need to be better …
Phenotypes of patients with COVID-19 who have a positive clinical response to helmet noninvasive ventilation
…, S Spadaro, MM Bitondo, C Berardi, T Rosà… - American Journal of …, 2022 - atsjournals.org
Methods A total of 109 patients admitted to four ICUs in Italy with COVID-19 and moderate
to severe hypoxemic respiratory failure (Pa O 2/F i O 2⩽ 200) were randomized to receive 48-…
to severe hypoxemic respiratory failure (Pa O 2/F i O 2⩽ 200) were randomized to receive 48-…
[HTML][HTML] Personalized respiratory support in ARDS: a physiology-to-bedside review
Acute respiratory distress syndrome (ARDS) is a leading cause of disability and mortality
worldwide, and while no specific etiologic interventions have been shown to improve outcomes…
worldwide, and while no specific etiologic interventions have been shown to improve outcomes…
[HTML][HTML] Helmet noninvasive support for acute hypoxemic respiratory failure: rationale, mechanism of action and bedside application
…, LS Menga, L Delle Cese, E Ruggiero, T Rosà… - Annals of Intensive …, 2022 - Springer
Introduction Helmet noninvasive support may provide advantages over other noninvasive
oxygenation strategies in the management of acute hypoxemic respiratory failure. In this …
oxygenation strategies in the management of acute hypoxemic respiratory failure. In this …
Effect of a pre-emptive 2-hour session of high-flow nasal oxygen on postoperative oxygenation after major gynaecologic surgery: a randomised clinical trial
Background We aimed at determining whether a 2-h session of high-flow nasal oxygen (HFNO)
immediately after extubation improves oxygen exchange after major gynaecological …
immediately after extubation improves oxygen exchange after major gynaecological …
[HTML][HTML] Recruitment-to-inflation ratio assessed through sequential end-expiratory lung volume measurement in acute respiratory distress syndrome
DL Grieco, G Pintaudi, F Bongiovanni… - …, 2023 - pubs.asahq.org
Background Positive end-expiratory pressure (PEEP) benefits in acute respiratory distress
syndrome are driven by lung dynamic strain reduction. This depends on the variable extent of …
syndrome are driven by lung dynamic strain reduction. This depends on the variable extent of …
[HTML][HTML] Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation
Introduction Remdesivir and Dexamethasone represent the cornerstone of therapy for critically
ill patients with acute hypoxemic respiratory failure caused by Coronavirus Disease 2019 …
ill patients with acute hypoxemic respiratory failure caused by Coronavirus Disease 2019 …
Dyspnoea and clinical outcome in critically ill patients receiving noninvasive support for COVID-19 respiratory failure: post hoc analysis of a randomised clinical trial
In non-COVID-19 acute hypoxaemic respiratory failure, the entity of dyspnoea has been
associated with severity of hypoxaemia, and represents a factor predicting noninvasive …
associated with severity of hypoxaemia, and represents a factor predicting noninvasive …